leukemia Archives

leukemia

Early results from immunotherapy in patients with advanced leukemia positive

April 28, 2016

A small, early study in the Journal of Clinical Investigation reports that 93% of patients with advanced leukemia were in remission after immunotherapy. Read more and access the study.

FDA approved first gene therapy in U.S.

August 30, 2017

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA Commissioner Scott Gottlieb, M.D.…

FDA approves Marqibo for rare type of leukemia

August 11, 2012

On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).…

mylotrag treatment acute myeloid leukemia

FDA approves new drug for acute myeloid leukemia

September 8, 2017

On Sept. 1, the U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express…

$relapsed or refractory acute lymphoblastic leukemia$

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

August 22, 2017

On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia…